BIAL Announces First Patient Out in its Phase 2 Clinical Trial of BIA 28-6156 - a Novel Therapy for GBA1 Parkinson's Disease Porto, Portugal (OTE) - BIAL, a hundred-year-old innovation-driven biopharm ...